دورية أكاديمية
أعرض في EDS

Analysis of Nuclear Encoded Mitochondrial Gene Networks in Cervical Cancer.

التفاصيل البيبلوغرافية
العنوان: Analysis of Nuclear Encoded Mitochondrial Gene Networks in Cervical Cancer.
المؤلفون: Meneur C; Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India.; La Rochelle University, Avenue Albert Einstein, 17031, La Rochelle, France., Eswaran S; Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India., Adiga D; Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India., S S; Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India., G NK; Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India., Mallya S; Department of Bioinformatics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India., Chakrabarty S; Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India., Kabekkodu SP; Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India.
المصدر: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2021 Jun 01; Vol. 22 (6), pp. 1799-1811. Date of Electronic Publication: 2021 Jun 01.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Asian Pacific Organization for Cancer Prevention Country of Publication: Thailand NLM ID: 101130625 Publication Model: Electronic Cited Medium: Internet ISSN: 2476-762X (Electronic) Linking ISSN: 15137368 NLM ISO Abbreviation: Asian Pac J Cancer Prev Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Bangkok : Asian Pacific Organization for Cancer Prevention,
مواضيع طبية MeSH: Gene Regulatory Networks* , Genes, Mitochondrial*, Biomarkers, Tumor/*genetics , Uterine Cervical Neoplasms/*genetics, DNA Methylation ; Datasets as Topic ; Disease Progression ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Prognosis
مستخلص: Background: Cervical cancer (CC) is one of the most common female cancers in many developing and underdeveloped countries. High incidence, late presentation, and mortality suggested the need for molecular markers. Mitochondrial defects due to abnormal expression of nuclear-encoded mitochondrial genes (NEMG) have been reported during cancer progression. Nevertheless, the application of NEMG for the prognosis of CC is still elusive. Herein, we aimed to investigate the associations between NEMG and CC prognosis.
Materials and Methods: The differentially expressed genes (DEG) in the TCGA-CESC dataset and NEMGs were retrieved from TACCO and Mitocarta2.0 databases, respectively. The impact of methylation on NEMG expression were predicted using DNMIVD and UALCAN tools. HCMDB tool was used to predict genes having metastatic potential. The prognostic models were constructed using DNMIVD, TACCO, GEPIA2, and SurvExpress. The functional enrichment analysis (FEA) was performed using clusterProfiler. The protein-protein interaction network (PPIN) was constructed to identify the hub genes (HG) using String and CytoHubba tools. Independent validation of the HG was performed using Oncomine and Human Protein Atlas databases. The druggable genes were predicted using DGIdb.
Results: Among the 52 differentially expressed NEMG, 15 were regulated by DNA methylation. The expression level of 16, 10, and 7 has the potential for CC staging, prediction of metastasis, and prognosis. Moreover, 1 driver gene and 16 druggable genes were also identified. The FEA identified the enrichment of cancer-related pathways, including AMPK and carbon metabolism in cancer. The combined expression of 10 HG has been shown to affect patient survival.
Conclusion: Our findings suggest that the abnormal expression of NEMGs may play a critical role in CC development and progression. The genes identified in our study may serve as a prognostic indicator and therapeutic target in CC.
.
References: Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1031-1036. (PMID: 31030470)
Neoplasia. 2007 Feb;9(2):166-80. (PMID: 17356713)
Prostate. 2020 Sep;80(12):950-961. (PMID: 32648618)
Cancer Manag Res. 2020 Aug 25;12:7827-7835. (PMID: 32943924)
Nucleic Acids Res. 2016 Jan 4;44(D1):D1251-7. (PMID: 26450961)
Cell Metab. 2018 Jan 9;27(1):136-150.e5. (PMID: 29249690)
Nucleic Acids Res. 2020 Jan 10;48(1):16-35. (PMID: 31754720)
J Biol Chem. 2014 Apr 11;289(15):10637-10649. (PMID: 24570007)
Oncogene. 2006 Aug 7;25(34):4663-74. (PMID: 16892080)
J Cancer. 2020 Mar 4;11(10):3041-3051. (PMID: 32226519)
Int J Oncol. 2017 Jun;50(6):2011-2023. (PMID: 28498475)
BMC Syst Biol. 2014;8 Suppl 4:S11. (PMID: 25521941)
Oncotarget. 2016 Feb 2;7(5):5193-203. (PMID: 26621844)
Cancer Lett. 2006 Feb 28;233(2):297-308. (PMID: 15885896)
Cancer Lett. 2018 Aug 10;429:89-99. (PMID: 29753758)
Br J Cancer. 2017 Mar 28;116(7):930-936. (PMID: 28208156)
Cancer Lett. 2020 Mar 31;473:74-89. (PMID: 31904482)
Ann Transl Med. 2019 Nov;7(22):682. (PMID: 31930083)
OMICS. 2012 May;16(5):284-7. (PMID: 22455463)
Cancer Med. 2019 Dec;8(18):7762-7773. (PMID: 31663688)
Cell. 2007 Apr 6;129(1):111-22. (PMID: 17418790)
Nucleic Acids Res. 2018 Jan 4;46(D1):D1068-D1073. (PMID: 29156001)
Yonsei Med J. 2016 Jul;57(4):865-71. (PMID: 27189278)
Nat Rev Mol Cell Biol. 2019 May;20(5):267-284. (PMID: 30626975)
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560. (PMID: 31114875)
Protein Sci. 2018 Jan;27(1):233-244. (PMID: 28940711)
Neoplasia. 2017 Aug;19(8):649-658. (PMID: 28732212)
Nucleic Acids Res. 2019 Jan 8;47(D1):D948-D954. (PMID: 30247620)
Nucleic Acids Res. 2020 Jan 8;48(D1):D856-D862. (PMID: 31598709)
Semin Oncol Nurs. 2019 Apr;35(2):166-174. (PMID: 30878194)
Genome Res. 2003 Nov;13(11):2498-504. (PMID: 14597658)
Nucleic Acids Res. 2018 Jan 4;46(D1):D950-D955. (PMID: 29088455)
Nucleic Acids Res. 2011 Jan;39(Database issue):D975-9. (PMID: 21045064)
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818767455. (PMID: 29642758)
Nucleic Acids Res. 2020 Jan 8;48(D1):D863-D870. (PMID: 31701128)
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819871306. (PMID: 31530094)
PLoS One. 2013 Sep 16;8(9):e74250. (PMID: 24066126)
Lancet. 2020 Feb 22;395(10224):591-603. (PMID: 32007142)
Oncogenesis. 2017 Apr 17;6(4):e319. (PMID: 28414320)
BMC Womens Health. 2020 Jul 2;20(1):139. (PMID: 32615963)
Contemp Oncol (Pozn). 2015;19(1A):A68-77. (PMID: 25691825)
Int J Med Sci. 2019 Jun 2;16(6):800-812. (PMID: 31337953)
Lancet Glob Health. 2020 Feb;8(2):e191-e203. (PMID: 31812369)
Environ Health Perspect. 2014 Dec;122(12):1271-8. (PMID: 25127496)
Biochim Biophys Acta. 2011 Jun;1807(6):735-45. (PMID: 21453675)
Gynecol Oncol. 2018 Jul;150(1):190-200. (PMID: 29606483)
Nucleic Acids Res. 2000 Jan 1;28(1):27-30. (PMID: 10592173)
Sci Rep. 2019 Mar 7;9(1):3877. (PMID: 30846808)
Comput Struct Biotechnol J. 2019 Feb 07;17:241-250. (PMID: 30847042)
CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
فهرسة مساهمة: Keywords: Cervical cancer; Nuclear encoded mitochondrial genes; Prognosis; TCGA-CESC; survival
المشرفين على المادة: 0 (Biomarkers, Tumor)
تواريخ الأحداث: Date Created: 20210628 Date Completed: 20211207 Latest Revision: 20231107
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC8418845
DOI: 10.31557/APJCP.2021.22.6.1799
PMID: 34181336
قاعدة البيانات: MEDLINE
الوصف
تدمد:2476-762X
DOI:10.31557/APJCP.2021.22.6.1799